Development and validation of the chronic hepatitis C virus treatment satisfaction (HCVTSat) instrument
Authors:
- 7 January 2013
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 37 (5) , 573-582
Abstract
Summary: Background: While current medications used to treat patients with chronic hepatitis C virus (HCV) effectively produce sustained viral response (SVR), postponement of therapy is oftentimes attributed to patient perceptions of unfavourable outcomes. However, an instrument to assess patient perceptions of therapy (i.e. treatment satisfaction) has not been developed.Aim: To describe the development and validation the chronic Hepatitis C Virus Treatment Satisfaction (HCVTSat) instrument.Methods: Focus groups, expert review and cognitive debriefing were used to develop a draft 37‐item instrument (scale: 1 = not important at all; 5 = extremely important). The preliminary instrument was administered to a pre‐test sample of 145 patients through Mayo Clinic, Rochester, MN. A refined HCVTSat was administered to a main sample of 333 participants with a chronic HCV diagnosis through Harris Interactive.Results: The HCVTSat was completed by 333 participants with an average age of 51 (s.d. = 12.1) years, 55% male, current or previous HCV treatment experience, and a diagnosis of HCV for approximately 12 (s.d. = 8.9) years. Twelve items for the 3 dimensions, Treatment Experience (TE), Side Effects (SE) and Social Aspects (SA), were internally consistent (Cronbach's α range: 0.70–0.90), responsive and valid. Confirmatory factor analysis (goodness‐of‐fit indexes: χ2 = 20.9, df = 23, P = 0.59; CFI = 1.00, GFI = 0.99, TFI = 1.00, RMSEA = 0.001) revealed a better fit with 9 items. All path coefficients were significant (P < 0.05). SE and SA were strong predictors of TE, while TE was positively associated with the 1‐item global measure of TS (path coefficient = 0.12).Conclusions: The 10‐item HCVTSat demonstrated valid psychometric properties and assessed patient satisfaction with HCV therapies. However, additional studies are needed to validate the HCVTSat in conjunction with SVR and in patients in underrepresented populations.Keywords
This publication has 32 references indexed in Scilit:
- Treatment Satisfaction in Osteoarthritis and Chronic Low Back Pain: The Role of Pain, Physical and Emotional Functioning, Sleep, and Adverse EventsThe Journal of Pain, 2011
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus InfectionGastroenterology, 2011
- Evolving epidemiology of hepatitis C virusClinical Microbiology and Infection, 2011
- Effect of hepatitis C virus and its treatment on survival†‡Hepatology, 2009
- Specialty care and education associated with greater disease‐specific knowledge but not satisfaction with care for chronic hepatitis CAlimentary Pharmacology & Therapeutics, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Co‐morbid medical and psychiatric illness and substance abuse in HCV‐infected and uninfected veteransJournal of Viral Hepatitis, 2007
- Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective studyGut, 2007
- Reasons Why Patients Infected with Chronic Hepatitis C Virus Choose to Defer Treatment: Do They Alter Their Decision with Time?Digestive Diseases and Sciences, 2007
- Management of Patients With Hepatitis C in a Community Population: Diagnosis, Discussions, and Decisions to TreatThe Annals of Family Medicine, 2004